CD30-positive atypical lymphoid cells in common non-neoplastic cutaneous infiltrates rich in neutrophils and eosinophils

American Journal of Surgical Pathology

Volumn 27, Issue 7, 2003, Pages 912-918

  Cepeda, Laura T ^b   Pieretti, Maura ^b   Chapman, Sandra F ^b   Horenstein, Marcelo G ^a  

^a UNIVERSITY OF SOUTH ALABAMA   (United States)

^b NONE

Author keywords

CD30; HIV; Inflammation; Lymphoma; PCR

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; CD30 ANTIGEN; IMMUNOGLOBULIN;

ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; ADULT; AGED; ARTICLE; B LYMPHOCYTE; BACTERIAL INFECTION; CELL COUNT; CLINICAL ARTICLE; CLONAL VARIATION; CYST RUPTURE; DIFFERENTIAL DIAGNOSIS; EOSINOPHIL; FEMALE; HUMAN; HUMAN TISSUE; INFLAMMATORY INFILTRATE; INSECT BITE; LARGE CELL LYMPHOMA; LYMPHOID CELL; LYMPHOMATOID PAPULOSIS; MALE; MYCOSIS; NEUTROPHIL; PLASMA CELL; POLYMERASE CHAIN REACTION; SKIN INFILTRATE; SPIDER BITE; SUPPURATIVE HIDRADENITIS; T LYMPHOCYTE; VIRUS INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD30; CELL COUNT; CLONE CELLS; DIAGNOSIS, DIFFERENTIAL; DNA; EOSINOPHILS; FEMALE; GENE REARRANGEMENT, B-LYMPHOCYTE; GENE REARRANGEMENT, T-LYMPHOCYTE; HUMANS; INSECT BITES AND STINGS; LYMPHOMA, LARGE-CELL; LYMPHOMATOID PAPULOSIS; MALE; MIDDLE AGED; NEUTROPHILS; POLYMERASE CHAIN REACTION; SKIN; SKIN DISEASES; SKIN NEOPLASMS;

EID: 0038339501     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200307000-00006     Document Type: Article

References (23)

1. Alzona M, Jack HM, Fisher RI, et al. CD30 defines a subset of activated human T cells that produce IFN-gamma and IL-5 and exhibit enhanced B cell helper activity. J Immunol 1994;153:2861-7.
2. Del Prete G, De Carli M, Almefigogna F, et al. Preferential expression of CD30 by human CD4+ T cells producing Th2-type cytokines. FASEB J 1995;9:81-6.
3. Diaz-Cascajo C. Strong immunoexpression of the monoclonal antibody CD-30 in lymphocytic infiltrates of the skin not by itself evidence for diagnosing malignant lymphoma. Am J Dermatopathol 2001;23:79-80.
4. Ellis TM, Simms PE, Slivnick DJ, et al. CD30 is a signal-transducing molecule that defines a subset of human activated CD45RO+ Tcells. J Immunol 1993;151:2380-9.
5. Guitart J, Hurt MA. Pleomorphic T-cell infiltrate associated with molluscum contagiosum. Am J Dermatopathol 1999;21:178-80.
6. Hamann D, Hilkens CM, Grogan JL, et al. CD30 expression does not discriminate between human Th1- and Th2-type T cells. J Immunol 1996;156:1387-91.
7. Jhala DN, Medeiros LJ, Lopez-Terrada D, et al. Neutrophil-rich anaplastic large cell lymphoma of T-cell lineage: a report of two cases arising in HIV-positive patients. Am J Clin Pathol 2000;114:478-82.
8. Kadin M, Nasu K, Sako D, et al. Lymphomatoid papulosis: a cutaneous proliferation of activated helper T cells expressing Hodgkin's disease-associated antigens. Am J Pathol 1985;119:315-25.
9. Keane NM, Price P, Lee S, et al. An evaluation of serum soluble CD30 levels and serum CD26 (DPPIV) enzyme activity as markers of type 2 and type 1 cytokines in HIV patients receiving highly active antiretroviral therapy. Clin Exp Immunol 2001;126:111-6.
10. Mann KP, Hall B, Kamino H, et al. Neutrophil-rich, Ki-1-positive anaplastic large-cell malignant lymphoma. Am J Surg Pathol 1995;19:407-16.
11. McCalmont TH, LeBoit PE. A lymphomatoid papule, but not lymphomatoid papulosis! Am J Dermatopathol 2000;22:188-90.
12. Nathan DL, Belsito DV. Carbamazepine-induced pseudolymphoma with CD-30 positive cells. J Am Acad Dermatol 1998;38:806-9.
13. Nihal M, Mikkola D, Wood GS. Detection of clonally restricted immunoglobulin heavy chain gene rearrangements in normal and lesional skin: analysis of the B cell component of the skin-associated lymphoid tissue and implications for the molecular diagnosis of cutaneous B cell lymphomas. J Mol Diagn 2000;2:5-10.
14. Pieretti M, Cavalieri C, Conway PS, et al. Genetic alterations distinguish different types of ovarian tumors. Int J Cancer 1995;64:434-40.
15. Piletta PA, Wirth S, Hommel L, et al. Circulating skin-homing T cells in atopic dermatitis: selective up-regulation of HLA-DR, interleukin-2R, and CD30 and decrease after combined UV-A and UV-B phototherapy. Arch Dermatol 1996;132:1171-6.
16. Plumbley JA, Fan H, Eagan PA, et al. Lymphoid tissues from patients with infectious mononucleosis lack monoclonal B and T cells. J Mol Diagn 2002;4:37-43.
17. Saeed SA, Bazza M, Zaman M, et al. Cefuroxime induced lymphomatoid hypersensitivity reaction. Postgrad Med J 2000;76:577-9.
18. Schwab U, Stein H, Gerdes J, et al. Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature 1982;299:65-7.
19. Schwarting R, Gerdes J, Durkop H, et al. BER-H2: a new anti-Ki-1 (CD30) monoclonal antibody directed at a formol-resistant epitope. Blood 1989;74:1678-89.
20. Smoller BR, Longacre TA, Wamke RA. Ki-1 (CD30) expression in differentiation of lymphomatoid papulosis from arthropod bite reactions. Mod Pathol 1992;5:492-6.
21. Smoller BR, Stewart M, Warnke R. A case of Woringer-Kolopp disease with Ki-1 (CD30) + cytotoxic/suppressor cells. Arch Dermatol 1992;128:526-9.
22. Stein H, Mason DY, Gerdes J, et al. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 1985;66:848-58.
23. Willemze R, Kerl H, Sterry W, et al. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 1997;90:354-71.